Skip to main content
SpringerLink
Log in

Depressants

  • Chapter
Drug and Alcohol Abuse

  • 2380 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 199.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Ballenger, J. C. Benzodiazepine receptor agonists and antagonists. In B. J. Sadock, & V. A. Sadock (Eds.), Kaplan & Sadock’s Comprehensive Textbook of Psychiatry (7th ed.). Baltimore, MD: Lippincott, Williams & Wilkins, 2000, pp. 2317–2323.

    Google Scholar 

  2. Wesson, D. R., Smith, D. E., Ling, W., & Seymour, R. B. Sedative-hypnotics. In J. H. Lowinson, P. Ruiz, R. B. Millman, & J. G. Langrod (Eds.), Substance Abuse: A Comprehensive Textbook (4th ed.). Baltimore, MD: Lippincott, Williams & Wilkins, 2004, pp. 302–312.

    Google Scholar 

  3. Evers, A. S., & Crowder, C. M. General anesthetics. In J. G. Hardman, L. E. Limbird, & A. G. Goodman (Eds.), The Pharmacological Basis of Therapeutics (10th ed.). New York: McGraw-Hill, 2001, pp. 337–366.

    Google Scholar 

  4. Charney, D. S., Mihic, J., & Harris, R. A. Hypnotics and sedatives. In J. G. Hardman, L. E. Limbird, & A. G. Goodman (Eds.), The Pharmacological Basis of Therapeutics (10th ed.). New York: McGraw-Hill, 2001, pp. 399–427.

    Google Scholar 

  5. O’Brien, C. P. Drug addiction and drug abuse, In J. G. Hardman, L. E. Limbird, & A. G. Goodman (Eds.), The Pharmacological Basis of Therapeutics (10th ed.). New York: McGraw-Hill, 2001, pp. 621–642.

    Google Scholar 

  6. Brancucci, A., Berretta, N., Mercuri, N. B., & Francesconi, W. Presynaptic modulation of spontaneous inhibitory postsynaptic currents by gamma-hydroxyburyrate in the substantia nigra pars compacta. Neuropsychopharmacology 29:537–543, 2004.

    Article  PubMed  Google Scholar 

  7. Stoops, W. W., & Rush, C. R. Differential effects in humans after repeated administrations of zolpidem and triazolam. The American Journal of Drug and Alcohol Abuse. 29:281–299, 2003.

    Article  PubMed  Google Scholar 

  8. Szabo, S. T., Gold, M. S., Goldberg, B. A., & Blier, P. Effects of sustained gammahydroxybutyrate treatments on spontaneous and evoked firing activity of locus coeruleus norepinephrine neurons. Biological Psychiatry 55:934–939, 2004.

    Article  PubMed  Google Scholar 

  9. Girdler, N. M., Lyne, J. P., Wallace, R., Neave, N., Scholey, A., Wesnes, K. A., & Herman, C. A randomized controlled trial of cognitive and psychomotor recovery from midazolam sedation following reversal with oral flumazenil. Anaesthesia 57:868–876, 2002.

    Article  PubMed  Google Scholar 

  10. Bloom, F. E. Neurotransmission and the central nervous system. In J. G. Hardman, L. E. Limbird, & A. G. Goodman (Eds.), The Pharmacological Basis of Therapeutics (10th ed.). New York: McGraw-Hill, 2001, pp. 293–320.

    Google Scholar 

  11. Flaishon, R., Weinbroum, A. A., Veenman, L., Leschiner, S., Ruddick, V., & Gavish, M. Flumazenil attenuates development of tolerance to diazepam after chronic treatment of mice with either isoflurane or diazepam. Anesthesia & Analgesia 97:1046–1052, 2003.

    Article  Google Scholar 

  12. Allison, C., Claase, L. A., & Pratt, J. A. Diazepam withdrawal-induced anxiety and place aversion in the rat: Differential effects of two chronic diazepam treatment regimes. Behavioral Pharmacology 13:417–425, 2002.

    Google Scholar 

  13. Gerra, G., Zaimovic, A., Giusti, F., Moi, G., & Brewer, C. Intravenous flumazenil versus oxazepam tapering in the treatment of benzodiazepine withdrawal: A randomized, placebocontrolled study. Addictive Biology 7:385–395, 2002.

    Article  Google Scholar 

  14. McGregor, C., Machin, A., & White, J. M. In-patient benzodiazepine withdrawal: Comparison of fixed and symptom-triggered taper methods. Drug and Alcohol Review 22:175–180, 2003.

    Article  PubMed  Google Scholar 

  15. Chand, P. K., & Murthy, P. Megadose lorazepam dependence. Addiction 98:1633–1636, 2003.

    Article  Google Scholar 

  16. Hajak, G., Müller, W. E., Wittchen, H. U., Pittrow, D., & Kirch, W. Abuse and dependence potential for the non-benzodiazepine hypnotics zolpidem and zopiclone: A review of case reports and epidemiological data. Addiction 98:1371–1378, 2003.

    Article  PubMed  Google Scholar 

  17. Rosenberg, R., Caron, J., Roth, T., & Amato, D. An assessment of the efficacy and safety of eszopiclone in the treatment of transient insomnia in healthy adults. Sleep Medicine 6:15–22, 2005.

    Article  PubMed  Google Scholar 

  18. Cammarano, W. B., Pittet, J. F., Weitz, S., Schlobohm, R. M., & Marks, J. D. Acute withdrawal syndrome related to the administration of analgesic and sedative medications in adult intensive care unit patients. Critical Care Medicine 26:676–684, 1998.

    Article  PubMed  Google Scholar 

  19. Gatzonis, S. D., Angelopoulos, E. K., Daskalopoulou, E. G., et al. Convulsive status epilepticus following abrupt high-dose benzodiazepine discontinuation. Drug and Alcohol Dependence 59:95–97, 2000.

    Article  PubMed  Google Scholar 

  20. Darke, S., Topp, L., & Ross, J. The injection of methadone and benzodiazepines among Sydney injecting drug users 1996–2000: 5-year monitoring of trends from the illicit drug reporting system. Drug and Alcohol Review 21:27–32, 2002.

    Article  PubMed  Google Scholar 

  21. Ross, J., & Darke, S. The nature of benzodiazepine dependence among heroin users in Sydney, Australia. Addiction 95:1785–1793, 2000.

    Article  PubMed  Google Scholar 

  22. American Psychiatric Association. The Diagnostic and Statistical Manual of Mental Disorders (4th ed. revised text) Washington, DC: American Psychiatric Press, 2000.

    Google Scholar 

  23. Beaumont, M., Batejat, D., Coste, O., van Beers, P., Colas, A., Clere, J.-M., & Pierard, C. Effects of zolpidem and zaleplon on sleep, respiratory patterns and performance at a simulated altitude of 4,000 m. Neuropsychobiology 49:154–162, 2004.

    Article  PubMed  Google Scholar 

  24. Drover, D. R. Comparative pharmacokinetics and pharmacodynamics of short-acting hypnosedatives: Zaleplon, zolpidem, and zopiclone. Clinical Pharmacokinetics 43:227–238, 2004.

    Article  PubMed  Google Scholar 

  25. Berthelon, C., Bocca, M. L., Denise, P., & Pottier, A. Do zopiclone, zolpidem and flunitrazepam have residual effects on stimulated task of collision anticipation? Journal of Psychopharmacology 17:324–331, 2003.

    Article  PubMed  Google Scholar 

  26. Gahlinger, P. M. Club drugs: MDMA, gamma-hydroxybutyrate (GHB), rophynol and ketamine. American Family Physician 69:2619–2626, 2004.

    PubMed  Google Scholar 

  27. Lader, M. Iatrogenic sedative dependence and abuse—Have doctors learnt caution? Addiction 93:1133–1135, 1998.

    Article  PubMed  Google Scholar 

  28. Ancoli-Israel, S. All I Want is a Good Night’s Sleep. St. Louis, MO: Mosby Publishing Co., 1996.

    Google Scholar 

  29. Rickels, K., DeMartinis, N., Garcia-Espana, F., Greenblatt, D. J., et al. Imipramine and buspirone in treatment of patients with generalized anxiety disorder who are discontinuing longterm benzodiazepine therapy. American Journal of Psychiatry 57:1973–1979, 2000.

    Article  Google Scholar 

  30. Wang, P. S., Bohn, R. L., Glynn, R. J., Mogun, H., & Avorn, J. Hazardous benzodiazepine regimens in the elderly: Effects of half-life, dosage, and duration on risk of hip fracture. American Journal of Psychiatry 158:892–898, 2001.

    PubMed  Google Scholar 

  31. Buck, K. J., & Finn, D. A. Genetic factors in addiction: QTL mapping and candidate gene studies implicate GABAergic genes in alcohol. Addiction 96:139–149, 2000.

    Article  Google Scholar 

  32. McKernan, R. M., Rosahl, T.W., Reynolds, D. S., Sur, C., Wafford, K. A., et al. Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABAa receptor a! subtype. Nature Neuroscience 3:587–592, 2000.

    Article  PubMed  Google Scholar 

  33. Olshaker, J. S., & Flanigan, J. Flumazenil reversal of lorazepam-induced acute delirium. Journal of Emergency Medicine 24:181–183, 2003.

    Article  PubMed  Google Scholar 

  34. Sanders-Bush, E., & Mayer, S. E. 5-Hydroxytryptamine (Serotonin): Receptor Agonists and Antagonists. In J. G. Hardman, L. E. Limbird, & A. G. Goodman (Eds.), The Pharmacological Basis of Therapeutics (10th ed.). New York: McGraw-Hill, 2001, pp. 205–222.

    Google Scholar 

  35. Liu, Y. P., Wilkinson, L. S., & Robbins, T. W. Effects of acute and chronic buspirone on impulsive choice and efflux of 5-HT and dopamine in hippocampus, nucleus accumbens, and prefrontal cortex. Psychopharmcology 173:175–185, 2004.

    Article  Google Scholar 

  36. Rynn, M., Garcia-Espana, F., Greenblatt, D. J., Mandos, L. A., Schweizer, E, & Rickels K. Imipramine and buspirone in patients with panic disorder who are discontinuing long-term benzodiazepine therapy. Journal of Clinical Psychopharmacology 25:505–508, 2003.

    Article  Google Scholar 

  37. Carter, L. P., Chen, W., Wu, H., Mehta, A. K., Hernandez, R. J., Ticku, M. K., Coop, A., Koek, W., & France, C. P. Comparison of the behavioral effects of gamma-hydroxybutyric acid (GHB) and its 4-methyl-substituted analog, gamma-hydroxyvaleric acid (GVB). Drug and Alcohol Dependence 78:91–99, 2005.

    Article  PubMed  Google Scholar 

  38. Reeves, J., & Duda, R. GHB/GBL intoxication and withdrawal: A review and case presentation. Addictive Disorders & Their Treatment 2:25–28, 2003.

    Article  Google Scholar 

  39. Rosenberg, M. H., Deerfield, L. J., & Baruch, E. M. Two cases of severe gammahydroxbutyrate withdrawal delirium on a psychiatric unit: Recommendations for management. The American Journal of Drug and Alcohol Abuse 29:487–496, 2003.

    Article  PubMed  Google Scholar 

  40. Cairney, S., Clough, A. R., Maruff, P., Collie, A., Currie, B. J., & Currie, J. Saccade and cognitive function in chronic kava users. Neuropsychopharmacology 28:389–396, 2003.

    Article  PubMed  Google Scholar 

  41. Nowell, P. D., Mazumdar, S., Buysse, D. J., et al. Benzodiazepines and zolpidem for chronic insomnia: A meta-analysis of treatment efficacy. Journal of the American Medical Association 278:2170–2177, 1997.

    Article  PubMed  Google Scholar 

  42. McCabe, S. E. Correlates of nonmedical use of prescription benzodiazepine anxiolytics: Results from a national survey of U.S. college students. Drug and Alcohol Dependence 79:53–62, 2005.

    Article  PubMed  Google Scholar 

  43. Boixet, M., Batlle, E., & Bolibar, I. Benzodiazepines in primary health care: A survey of general practitioners prescribing patterns. Addiction 91:549–556, 1996.

    Article  PubMed  Google Scholar 

  44. Johnston, L. D., O’Malley, P. M., & Bachman, J. G. Monitoring the Future National Survey Results on Drug Use, 1975–2003. Vol. II: College Students and Adults Ages 19–40. (NIH Publication No. 04-5506). Bethesda, MD: National Institute on Drug Abuse, 2004.

    Google Scholar 

  45. Substance Abuse and Mental Health Services Administration. Overview of Findings from the 2002 National Survey on Drug Use and Health (Office of Applied Studies, NHSDA Series H-21, DHHS Publication No. SMA 03-3774). Rockville, MD, 2003.

    Google Scholar 

  46. Ross, J., Darke, S., & Hall, W. Transitions between routes of benzodiazepine administration among heroin users in Sydney. Addiction 92:697–705, 1995.

    Article  Google Scholar 

  47. Kasper, D. L., Braunwald, E., Fauci, A. S., et al. (Eds.), Harrison’s Principles of Internal Medicine (16th ed.). New York: McGraw-Hill, 2005.

    Google Scholar 

  48. Ma, O. J., & Cline, D.M. (Eds.), Emergency Medicine Manual (6th ed.). New York: McGraw-Hill, 2004.

    Google Scholar 

  49. Pomara, N., Willoughby, L., Wesnes, K., Greenblatt, D. J., & Sidtis, J. J. Apoliprotein E ∈ 4 allele and lorazepam effects on memory in high-functioning older adults. Archives of General Psychiatry 62:209–216, 2005.

    Article  PubMed  Google Scholar 

  50. Verster, J. C., Volkerts, E. R., & Verbaten, M. N. Effects of alprazolam on driving ability, memory functioning and psychomotor performance: A randomized, placebo-controlled study. Neuropsychopharmacology 27:260–269, 2002.

    Article  PubMed  Google Scholar 

  51. Sperling, R., Greve, D., Dale, A., Killiany, R., et al. Functional MRI detection of pharmacologically induced memory impairment. PNAS 99:455–460, 2002.

    Article  PubMed  Google Scholar 

  52. Mausner, K. L. Sedatives and hypnotics. In O. J. Ma, & D. M. Cline (Eds.), Emergency Medicine Manual (6th ed.). New York: McGraw-Hill, 2004, pp. 489–493.

    Google Scholar 

  53. Najarian, S. L. General management of the poisoned patient. In O. J. Ma, & D. M. Cline (Eds.), Emergency Medicine Manual (6th ed.). New York: McGraw-Hill, 2004, pp. 467–475.

    Google Scholar 

  54. Chang, G., & Kosten, T. R. Detoxification. In J. H. Lowinson, P. Ruiz, R. B. Millman, & J. G. Langrod (Eds.), Substance Abuse: A Comprehensive Textbook (4th ed.). Baltimore, MA: Lippincott, Williams & Wilkins, 2004, pp. 579–586.

    Google Scholar 

  55. Weinbroum, A. A., Flaishon, R., Sorkine, P., et al. A risk-benefit assessment of flumazenil in the management of benzodiazepine overdose. Drug Safety 17:181–196, 1997.

    PubMed  Google Scholar 

  56. Salzman, C. The APA task force report on benzodiazepine dependence, toxicity, and abuse. American Journal of Psychiatry 148:151–152, 1991.

    PubMed  Google Scholar 

  57. Kaminski, B. J., Sannerud, C. A., Weerts, E. M., Lamb, R. J., & Griffiths, R. R. Physical dependence in baboons chronically treated with low and high doses of diazepam. Behavioral Pharmacology 14:331–342, 2003.

    Google Scholar 

  58. Satel, S. L., Kosten, T. R., Schuckit, M. A., & Fischman, M. W. Should protracted withdrawal from drugs be included in DSM-IV? American Journal of Psychiatry 150:695–704, 1993.

    PubMed  Google Scholar 

  59. Vorma, H., Naukkarinen, H., Sarna, S., & Kuoppasalmi, K. Treatment of out-patients with complicated benzodiazepine dependence: Comparison of two approaches. Addiction 97:851–859, 2002.

    Article  PubMed  Google Scholar 

  60. Morin, C. M., Bastien, C., Guay, B., Radouco-Thomas, M., Leblanc, J., & Vallières, A. Randomized clinical trial of supervised tapering and cognitive behavior therapy to facilitate benzodiazepine discontinuation in older adults with chronic insomnia. American Journal of Psychiatry 161:332–342, 2004.

    Article  PubMed  Google Scholar 

  61. Koski, A., Ojanperä, I., & Vuori, E. Alcohol and benzodiazepines in fatal poisonings. Alcoholism: Clinical and Experimental Research 26:956–959, 2002.

    Article  Google Scholar 

  62. Anthenelli, R. M., Klein, J. L., Smith, T. L., & Schuckit, M. A. Comparison of the subjective and amnestic effects of diazepam and amobarbital in healthy young men. The American Journal of Addictions 2:131–140, 1993.

    Article  Google Scholar 

  63. Cummings, S. R., Nevitt, M. C., Browner, W. S., et al. Risk factors for hip fracture in white women. New England Journal of Medicine 332:767–773, 1995.

    Article  PubMed  Google Scholar 

  64. Tönne, U., Hiltunen, A. J., Vikander, B., et al. Neuropsychological changes during steadystate drug use, withdrawal and abstinence in primary benzodiazepine-dependent patients. Acta Psychiatrica Scandinavica 91:299–304, 1995.

    PubMed  Google Scholar 

  65. Fraser, A. A., & Ingram, I. M. Lorazepam dependence and chronic psychosis. British Journal of Psychiatry 147:211, 1985.

    Article  PubMed  Google Scholar 

  66. Martínez-Cano, H., de Iceta Ibáñez de Gauna, M., Vela-Bueno, A., & Wittchen, H. U. DSM-III-R co-morbidity in benzodiazepine dependence. Addiction 94:97–107, 1999.

    Article  PubMed  Google Scholar 

  67. Schuckit, M. A., Tipp, J. E., Bucholz, K. K., et al. The life time rates of three major mood disorders and four major anxiety disorders in alcoholics and controls. Addiction 92:1289–1304, 1997.

    Article  PubMed  Google Scholar 

  68. Schuckit, M. A., Tipp, J. E., Bergman, M., et al. Comparison of induced and independent major depressive disorders in 2,945 alcoholics. American Journal of Psychiatry 154:948–957, 1997.

    PubMed  Google Scholar 

  69. Preuss, U.W., Schuckit, M. A., Smith, T. L., Danko, G. P., Dasher, A. C., Hesselbrock, M. N., Hesselbrock, V. M., & Nurnberger, J. I., Jr. A comparison of alcohol-induced and independent depression in alcoholics with histories of suicide attempt. Journal of Studies on Alcohol 63:498–502, 2002.

    PubMed  Google Scholar 

  70. Kripke, D. F., Klauber, M. R., Wingard, D. L., et al. Mortality hazard associated with prescription hypnotics. Biological Psychiatry 43:687–693, 1998.

    Article  PubMed  Google Scholar 

  71. Dobbin, M., Martyres, R. F., Clode, D., & Champion de Crespigny, F. E. Association of benzodiazepine injection with the prescription of temazepam capsules. Drug and Alcohol Review 22:153–157, 2003.

    Article  PubMed  Google Scholar 

  72. Barbone, F., McMahon, A. D., Davey, P. G., et al. Association of road-traffic accidents with benzodiazepine use. Lancet 352:1331–1336, 1998.

    Article  PubMed  Google Scholar 

  73. Schuckit, M. A. A clinical review of interactions among medications. Developmental Disabilities: Clinical Insights 11, San Diego Regional Center for the Developmentally Disabled, 1998.

    Google Scholar 

  74. Bergman, U., Rosa, F. W., Baum, C., Wilhom, B. E., & Faich, G. A. Effects of exposure to benzodiazepine during fetal life. Lancet 340:694–696, 1992.

    Article  PubMed  Google Scholar 

  75. Steingart, R. A., Abu-Roumi, M., Newman, M. E., Silverman, W. F., Slotkin, T. A., & Yanai, J. Neurobehavioral damage to cholinergic systems caused by prenatal exposure to heroin or phenobarbital: Cellular mechanisms and the reversal of deficits by neural grafts. Developmental Brain Research 122:125–133, 2000.

    Article  PubMed  Google Scholar 

  76. Burt, V. K., Suri, R., Altshuler, L., Stowe, Z., et al. The use of psychotropic medications during breast-feeding. American Journal of Psychiatry 158:1101–1109, 2001.

    Article  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer Science+Business Media, Inc.

About this chapter

Cite this chapter

(2006). Depressants. In: Drug and Alcohol Abuse. Springer, Boston, MA. https://doi.org/10.1007/0-387-25733-0_2

Download citation

Publish with us

Policies and ethics

Search

Navigation